Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Raltégravir")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 213

  • Page / 9
Export

Selection :

  • and

Plasma and Intracellular Pharmacokinetics of Darunavir/ Ritonavir Once Daily and Raltegravir Once and Twice Daily in HIV-Infected IndividualsJACKSON, Akil; WATSON, Victoria; BOFFITO, Marta et al.Journal of acquired immune deficiency syndromes (1999). 2011, Vol 58, Num 5, pp 450-457, issn 1525-4135, 8 p.Article

Pharmacologie des inhibiteurs de l'intégrase du VIH = Clinical pharmacology of HIV integrase inhibitorsSOLAS-CHESNEAU, C; QUARANTA, S; LACARELLE, B et al.Virologie (Montrouge). 2009, Vol 13, Num MAI, issn 1267-8694, S25-S34, NSArticle

Raltegravir-induced cerebellar ataxiaREISS, Kim A; BAILEY, Justin R; PHAM, Paul A et al.AIDS (London). 2010, Vol 24, Num 17, issn 0269-9370, p. 2757Article

Selection of the Q148R integrase inhibitor resistance mutation in a failing raltegravir containing regimenROQUEBERT, Benedicte; BLUM, Laurent; COLLIN, Gilles et al.AIDS (London). 2008, Vol 22, Num 15, pp 2045-2046, issn 0269-9370, 2 p.Article

Exacerbation of depression associated with starting raltegravir : a report of four casesHARRIS, Marianne; LARSEN, Gerene; MONTANER, Julio S. G et al.AIDS (London). 2008, Vol 22, Num 14, pp 1890-1892, issn 0269-9370, 3 p.Article

Short Communication Lack of Correlation Between UGT1A1*6, *28 Genotypes, and Plasma Raltegravir Concentrations in Japanese HIV Type 1-Infected PatientsHIRANO, Atsushi; IKEMURA, Kenji; TAKAHASHI, Masaaki et al.AIDS research and human retroviruses. 2012, Vol 28, Num 8, pp 776-779, issn 0889-2229, 4 p.Article

Dynamics of Raltegravir Resistance Profile in an HIV Type 2-infected PatientLI XU; ANDERSON, Jane; GARRETT, Nigel et al.AIDS research and human retroviruses. 2009, Vol 25, Num 8, pp 843-847, issn 0889-2229, 5 p.Article

Lack of specificity for the analysis of raltegravir using online sample clean-up liquid chromatography-electrospray tandem mass spectrometryFRANCOIS JOURDIL, Jean; BARTOLI, Mireille; STANKE-LABESQUE, Françoise et al.Journal of chromatography. B. 2009, Vol 877, Num 29, pp 3734-3738, issn 1570-0232, 5 p.Article

Divalent Metals and pH Alter Raltegravir Disposition In VitroMOSS, Darren M; SICCARDI, Marco; MURPHY, Matthew et al.Antimicrobial agents and chemotherapy. 2012, Vol 56, Num 6, pp 3020-3026, issn 0066-4804, 7 p.Article

Persistent Prurigo Nodularis Responsive to Initiation of Combination Therapy With RaltegravirUNEMORI, Patrick; LESLIE, Kieron S; MAURER, Toby et al.Archives of dermatology (1960). 2010, Vol 146, Num 6, pp 682-683, issn 0003-987X, 2 p.Article

Raltegravir and Etravirine Are Active against HIV Type 1 Group OBRIZ, Veronica; GARRIDO, Carolina; POVEDA, Eva et al.AIDS research and human retroviruses. 2009, Vol 25, Num 2, pp 225-227, issn 0889-2229, 3 p.Article

Effects of Switching From Efavirenz to Raltegravir on Endothelial Function, Bone Mineral Metabolism, Inflammation, and Renal Function: A Randomized, Controlled TrialGUPTA, Samir K; DEMING MI; MOE, Sharon M et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 64, Num 3, pp 279-283, issn 1525-4135, 5 p.Article

The Activity of the Integrase Inhibitor Dolutegravir Against HIV-1 Variants Isolated From Raltegravir-Treated AdultsUNDERWOOD, Mark R; JOHNS, Brian A; SATO, Akihiko et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 61, Num 3, pp 297-301, issn 1525-4135, 5 p.Article

Next-Generation Integrase Inhibitors: Where to After Raltegravir?KARMON, Sharon L.Drugs (Basel). 2013, Vol 73, Num 3, pp 213-228, issn 0012-6667, 16 p.Article

Raltegravir central nervous system tolerability in clinical practice: results from a multicenter observational studyMADEDDU, Giordano; MENZAGHI, Barbara; RICCI, Elena et al.AIDS (London). 2012, Vol 26, Num 18, pp 2412-2415, issn 0269-9370, 4 p.Article

Pharmacokinetics of Raltegravir in Individuals With UGT1 A1 PolymorphismsWENNING, L. A; POETRY, A. S; LUNDE, N. M et al.Clinical pharmacology and therapeutics. 2009, Vol 85, Num 6, pp 623-627, issn 0009-9236, 5 p.Article

Update on Raltegravir and the Development of New Integrase Strand Transfer InhibitorsLEE SHAMROE, Caitlin; BOOKSTAVER, Paul Brandon; ROKAS, Kristina E. E et al.Southern medical journal (Birmingham, Ala. Print). 2012, Vol 105, Num 7, pp 370-378, issn 0038-4348, 9 p.Article

Effect of continuous venovenous hemodiafiltration on darunavir and raltegravir exposure after administration via a gastroduodenal tubeTAEGTMEYER, Anne B; MÜLLER, Veronique; KOVARI, Helen et al.AIDS (London). 2011, Vol 25, Num 10, pp 1339-1341, issn 0269-9370, 3 p.Article

Cross-resistance Profile of the Novel Integrase Inhibitor Dolutegravir (S/GSK1349572) Using Clonal Viral Variants Selected in Patients Failing RaltegravirCANDUCCI, Filippo; CERESOLA, Elisa R; BOERI, Enzo et al.The Journal of infectious diseases. 2011, Vol 204, Num 11, pp 1811-1815, issn 0022-1899, 5 p.Article

Effect of Raltegravir Resistance Mutations in HIV-1 Integrase on Viral FitnessZIXIN HU; KURITZKES, Daniel R.Journal of acquired immune deficiency syndromes (1999). 2010, Vol 55, Num 2, pp 148-155, issn 1525-4135, 8 p.Article

Raltegravir Penetration in Seminal Plasma of Healthy VolunteersCALCAGNO, Andrea; BONORA, Stefano; D'AVOLIO, Antonio et al.Antimicrobial agents and chemotherapy. 2010, Vol 54, Num 6, pp 2744-2745, issn 0066-4804, 2 p.Article

Characterization of Binding of Raltegravir to Plasma ProteinsBARAU, Caroline; FURLAN, Valérie; YAZDANPANAH, Yazdan et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 10, pp 5147-5150, issn 0066-4804, 4 p.Article

HIV-1 Integrase Sequence Variability in Antiretroviral Naïve Patients and in Triple-Class Experienced Patients Subsequently Treated with RaltegravirVARGHESE, Vici; LIU, Tommy F; RHEE, Soo-Yon et al.AIDS research and human retroviruses. 2010, Vol 26, Num 12, pp 1323-1326, issn 0889-2229, 4 p.Article

Severe rhabdomyolysis associated with raltegravir useZEMBOWER, Teresa R; GERZENSHTEIN, Lana; COLEMAN, Karen et al.AIDS (London). 2008, Vol 22, Num 11, pp 1382-1384, issn 0269-9370, 3 p.Article

A Randomized Phase 3 Study Comparing Once-Daily Elvitegravir With Twice-Daily Raltegravir in Treatment-Experienced Subjects With HIV-1 infection: 96-Week ResultsELION, Richard; MOLINA, Jean-Michel; CHUCK, Steven L et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 4, pp 494-497, issn 1525-4135, 4 p.Article

  • Page / 9